School teacher Julia Drake returned for a second summer under the STARS program. This year she examined the effects of cabozantinib in combination with a novel vascular disrupting agent OXi8007 to inhibit kidney tumor growth. A great opportunity to learn about orthotopic tumors and novel therapeutic drug regimens.
Steven Sun is a high school intern who worked under Dr. Li Liu's and Dr. Tianyuan Wang's mentorship during the summer of 2024. He investigated the effects of vascular disrupting agent (VDA) drugs on different kidney tumor models.